By David J. Posel | August 26, 2014 5:05AM The US Independent News

An investigation by Johns Hopkins University has just been released on Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States from 1999 to 2010, resting in the latest release of JAMA’s Internal Medicine Online Magazine.

The study was focused on the overdose mortality due to pharmaceuticals and pills mass-prescribed for chronic pain such as Vicodin and Percocet among others. The researchers conducted a time series analysis of medical cannabis laws and state level death certificates in the United States from 1999 to 2010, all 50 states were included. The study found that in these years, states with medical cannabis laws had a 24.8% lower mean annual opioid (pain pill) overdose mortality rate compared to states without medical cannabis laws. The paper also shows that this effect over time lowers mortality year-by-year after implementation of medical marijuana laws.

In secondary analyses the findings remain similar, leaving strong conclusions that the medical cannabis laws are associated with significantly lower state level RX overdose mortality rates, and they recommend integration with public policies.

“The difference is quite striking,” said study co-author Colleen Barry, a health policy researcher at Johns Hopkins Bloomberg School of Public Health in Baltimore. The shift showed up quite quickly and become visible the year after medical marijuana was accepted in each state”

Many natural supplement retailers and organic cooperatives have begun selling ArisiTol ahead of other CBD products, with national sales trends pulling upwards at a rapid pace. This new Cannabidiol product by Twin Falls Biotech has just topped new Cannabidiol quality ratings, and has less than 1 percent THC. The newest recommendation from ICOMR, a CBD industry watchdog group, was released publicly last week. ArisiTol is very unique in the market due to the unique delivery method and comfortable breath mint style tablet that was specifically designed for the 40+ Generation X and Baby Boomer markets. ArisiTol is currently the only product in its class with positive lab tests and user feedback ratings.

It has been shown that Charlotte’s Web type cultivars as derived from Industrial Hemp have been legal since 2003. Some companies like Michigan Herbal Remedies are supplying tested, high grade CBD hemp oil that mirrors the profile of what people are calling Charlotte’s Web as well as hemp oil drops for other conditions.

New ratings and social indicators are showing that products like ArisiTol are more effective for chronic pain, neurological and arthritic type conditions than others in its class because the supplement uses direct mouth absorption of the hemp oil CBD active; therefore bypassing the stomach gut and liver which in turn delivers the highest percentage of available Cannabinoids to enter the bloodstream.

Twin Falls biotech has conducted extensive research on various oral CBD delivery mechanisms including drops, sprays and gum. TwinFalls has found a mint lozenge tablet to be the most beneficial delivery method, which is discrete and is easy for those 40 with dental appliances or require a sugar-free solution. The product is now available on Amazon and eBay for those customers as well as select online stores and direct purchase.

With products like ArisiTol selling a guaranteed and tested monthly CBD solution for less than a C-note; others are having a hard time keeping up the pace. As more studies point to CBD as an alternative for psychoactive drugs and opioids, we can certainly look forward to seeing a major shift in the future of healthcare and the well-being of our nation.

Source Article